Thinking of joining a study?

Register your interest

Become a volunteer?

Clinical trials

3144 results

Sort By:

CD19-BCMA Dual Nanobody Based CAR-T Cells for Patients With DSA

Study ID: NCT07451236
Start Date: 2026-03-18
End Date: 2027-12-31
Study Type

Interventional

Study Phase

Phase2

No. of Participants

18

Intervention / Treatment

CD19-BCMA dual nanobody based CAR-T Cells

Sponsor

Chang Yingjun

Source: clinicaltrials.gov

Share:
Add to list

A Phase 3 Study to Evaluate the Safety and Efficacy L606 in Participants With PH-ILD

Study ID: NCT07285655
Start Date: 2026-04
End Date: 2031-12
Study Type

Interventional

Study Phase

Phase3

No. of Participants

344

Intervention / Treatment

L606

Placebo

Sponsor

Liquidia Technologies, Inc.

Source: clinicaltrials.gov

Share:
Add to list

A Clinical Study of V540A in Healthy Female Participants (V540A-005)

Study ID: NCT07224477
Start Date: 2026-07-20
End Date: 2028-04-04
Study Type

Interventional

Study Phase

Phase2

No. of Participants

525

Intervention / Treatment

V540A-2

V540A-3

GARDASIL®9

Sponsor

Merck Sharp & Dohme LLC

Source: clinicaltrials.gov

Share:
Add to list

INVESTIGATION OF THE ANTI-NEOPLASTIC EFFECT OF TRISHUL (AYURVEDIC AGENT) ON TUMOUR REGRESSION OF RECTAL CANCER- A PILOT STUDY

Study ID: NCT07430696
Start Date: 2026-05-01
End Date: 2028-05-01
Study Type

Interventional

Study Phase

Phase2

No. of Participants

40

Intervention / Treatment

Trishul 750 Mag Badorli

Sponsor

University of Kelaniya

Source: clinicaltrials.gov

Share:
Add to list

Immune and Cognitive Benefits of Mango Intake in Young Adults

Study ID: NCT06229262
Start Date: 2026-05
End Date: 2026-12
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

54

Intervention / Treatment

Mango group

Sponsor

Loma Linda University

Source: clinicaltrials.gov

Share:
Add to list

PENG Block and Delirium After Hip Arthroplasty

Study ID: NCT07449468
Start Date: 2026-04-01
End Date: 2027-06-30
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

180

Intervention / Treatment

sham block with 0.9% sodium chloride

0.2% ropivacaine

Sponsor

Poznan University of Medical Sciences

Source: clinicaltrials.gov

Share:
Add to list

Arterial to Central co2gap in Relation to Outcome After Cardiopulmonary Bypass

Study ID: NCT06839027
Start Date: 2026-05-02
End Date: 2026-09-10
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

130

Intervention / Treatment
Sponsor

Ain Shams University

Source: clinicaltrials.gov

Share:
Add to list

Prenatal Haptonomy-Based Support

Study ID: NCT07417384
Start Date: 2026-04-01
End Date: 2027-04-30
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

36

Intervention / Treatment

Prenatal Haptonomy-Based Support

Mother-Supported Haptonomy Group

Midwife-Supported Haptonomy Group

Sponsor

Hilal Ozbek

Source: clinicaltrials.gov

Share:
Add to list

Study to Evaluate Safety and Efficacy of EG-301 in Patients With Nonfocal Geographic Atrophy Secondary to Dry-AMD

Study ID: NCT05170048
Start Date: 2026-06
End Date: 2028-06
Study Type

Interventional

Study Phase

Phase2

No. of Participants

90

Intervention / Treatment

EG-301

AREDS2 supplements

Sponsor

Evergreen Therapeutics, Inc.

Source: clinicaltrials.gov

Share:
Add to list

Examining Nurses' Trust and Acceptance of FAIR, an AI-powered Falls Risk Recommender

Study ID: NCT07078240
Start Date: 2027-01-01
End Date: 2029-06-30
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

60

Intervention / Treatment

Falls risk - Artificial Intelligence Recommender (FAIR)

modified Western Health Falls Risk Assessment Tool (mWHeFRA)

Sponsor

Tan Tock Seng Hospital

Source: clinicaltrials.gov

Share:
Add to list